BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND CALR, ENSG00000179218, 811, P27797, SSA, RO, FLJ26680, cC1qR AND Prognosis
43 results:

  • 1. Personalized treatment of well-differentiated gastric neuroendocrine tumors based on clinicopathological classification and grading: A multicenter retrospective study.
    Huang J; Liu H; Yang D; Xu T; Wang J; Li J
    Chin Med J (Engl); 2024 Mar; 137(6):720-728. PubMed ID: 38384175
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Diagnostic value of liver stiffness measurement combined with risk scores for esophagogastric variceal bleeding in patients with hepatitis B cirrhosis.
    Lin LY; Zeng DW; Liu YR; Zhu YY; Huang LL
    Eur J Radiol; 2024 Apr; 173():111385. PubMed ID: 38377895
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Novel prognostic indicator combining inflammatory indicators and tumor markers for gastric cancer.
    Yu L; Jiang R; Chen W; Liu Y; Wang G; Gong X; Wang Y
    World J Surg Oncol; 2023 Feb; 21(1):50. PubMed ID: 36803398
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Somatostatin-analog effect on pancreatic fistula after radical gastrectomy: a pilot randomized controlled trial.
    Sha S; Qiao W; Feng R; Lian G; Chen Y; Peng L; Wang J; Li L; Tian F; Jing C
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):6329-6339. PubMed ID: 36745222
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Factors, Including Clinical Trial Eligibility, Associated with Induction of Third-Line Treatment for Advanced gastric cancer.
    Ando T; Hosokawa A; Sakumura M; Motoo I; Kajiura S; Hirano K; Miwa T; Yokota T; Nakada N; Ueda Y; Ueda A; Tsukada K; Ogawa K; Nakaya A; Teramoto A; Nanjo S; Mihara H; Fujinami H; Fujii T; Yasuda I
    Oncology; 2023; 101(1):59-68. PubMed ID: 36103845
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Real-world comparison of healthcare resource utilization and costs of [
    Cox T; O'Connell M; Leeuwenkamp O; Palimaka S; Reed N
    Curr Med Res Opin; 2022 Aug; 38(8):1305-1317. PubMed ID: 35418254
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Well-differentiated gastroenteropancreatic G3 NET: findings from a large single centre cohort.
    Lithgow K; Venkataraman H; Hughes S; Shah H; Kemp-Blake J; Vickrage S; Smith S; Humphries S; Elshafie M; Taniere P; Diaz-Cano S; Dasari BVM; Almond M; Ford S; Ayuk J; Shetty S; Shah T; Geh I
    Sci Rep; 2021 Sep; 11(1):17947. PubMed ID: 34504148
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Value of HMGB1 expression for assessing gastric cancer severity: a systematic meta-analysis.
    Zhou C; Yang Q
    J Int Med Res; 2021 Mar; 49(3):300060521993312. PubMed ID: 33682495
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. First-line pembrolizumab/placebo plus trastuzumab and chemotherapy in HER2-positive advanced gastric cancer: KEYNOTE-811.
    Chung HC; Bang YJ; S Fuchs C; Qin SK; Satoh T; Shitara K; Tabernero J; Van Cutsem E; Alsina M; Cao ZA; Lu J; Bhagia P; Shih CS; Janjigian YY
    Future Oncol; 2021 Feb; 17(5):491-501. PubMed ID: 33167735
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [gastric adenocarcinoma with enteroblastic differentiation and elevated serum alpha fetoprotein].
    Li QZ; Zhao HB; Ban N; Wang Q; Zhang JJ; Ding SN; Li HH; Zhou ZH
    Zhonghua Bing Li Xue Za Zhi; 2020 Sep; 49(9):886-890. PubMed ID: 32892552
    [No Abstract]    [Full Text] [Related]  

  • 11. A comparison between triplet and doublet chemotherapy in improving the survival of patients with advanced gastric cancer: a systematic review and meta-analysis.
    Guo X; Zhao F; Ma X; Shen G; Ren D; Zheng F; Du F; Wang Z; Ahmad R; Yuan X; Zhao J; Zhao J
    BMC Cancer; 2019 Nov; 19(1):1125. PubMed ID: 31747911
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Impact of extranodal tumor deposits on prognosis and N stage in gastric cancer.
    Liang Y; Wu L; Liu L; Ding X; Wang X; Liu H; Meng J; Xu R; He D; Liang H
    Surgery; 2019 Sep; 166(3):305-313. PubMed ID: 31221435
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Comparison of the superiority of different TNM staging systems in Siewert III adenocarcinoma of esophagogastric junction].
    Lu Y; Xi H; Xie T; Qiu Z; Wang X; Wei B; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):143-148. PubMed ID: 30799536
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Predictive Value of Two Polymorphisms of ERCC2, rs13181 and rs1799793, in Clinical Outcomes of Chemotherapy in gastric cancer Patients: A Meta-Analysis.
    Li M; Zhao Y; Zhao E; Wang K; Lu W; Yuan L
    Dis Markers; 2018; 2018():3947626. PubMed ID: 30581498
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Intratumoral IL17-producing cells infiltration correlate with antitumor immune contexture and improved response to adjuvant chemotherapy in gastric cancer.
    Wang JT; Li H; Zhang H; Chen YF; Cao YF; Li RC; Lin C; Wei YC; Xiang XN; Fang HJ; Zhang HY; Gu Y; Liu X; Zhou RJ; Liu H; He HY; Zhang WJ; Shen ZB; Qin J; Xu JJ
    Ann Oncol; 2019 Feb; 30(2):266-273. PubMed ID: 30445581
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Subtype classification and clinicopathological characteristics of gastric neuroendocrine neoplasms: an analysis of 241 cases].
    Zhang P; Zhang Y; Zhang C; Shi Y; Liu J; Liu Q; Yu L; Wang M; Zou G; Lou J; Chen J; Tan H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1241-1246. PubMed ID: 27928793
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Revisiting a dogma: similar survival of patients with small bowel and gastric GIST. A population-based propensity score SEER analysis.
    Guller U; Tarantino I; Cerny T; Ulrich A; Schmied BM; Warschkow R
    Gastric Cancer; 2017 Jan; 20(1):49-60. PubMed ID: 26649434
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Clinicopathologic Significance and Prognostic Value of B7 Homolog 1 in gastric cancer: A Systematic Review and Meta-Analysis.
    Xu F; Feng G; Zhao H; Liu F; Xu L; Wang Q; An G
    Medicine (Baltimore); 2015 Oct; 94(43):e1911. PubMed ID: 26512615
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Modest overall survival improvements from 1998 to 2009 in metastatic gastric cancer patients: a population-based SEER analysis.
    Ebinger SM; Warschkow R; Tarantino I; Schmied BM; Güller U; Schiesser M
    Gastric Cancer; 2016 Jul; 19(3):723-34. PubMed ID: 26391158
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Surgery in oesophago-gastric cancer with metastatic disease: Treatment, prognosis and preoperative patient selection.
    Schmidt T; Alldinger I; Blank S; Klose J; Springfeld C; Dreikhausen L; Weichert W; Grenacher L; Bruckner T; Lordick F; Ulrich A; Büchler MW; Ott K
    Eur J Surg Oncol; 2015 Oct; 41(10):1340-7. PubMed ID: 26213358
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.